 |
| View general highlights and download
newsletters detailing events and information from recent medical
congresses. |
|
- Resynchronisation therapy affords significant protection against sudden
death in selected heart failure patients.
Heart Failure Update 2002
Oslo, May 2002
- Technologies take heart failure diagnosis to new levels with roles
for PET, stress echocardiography, and MRI.
14th World Congress of Cardiology (WCC)
Sydney, May 2002
- Among patients undergoing major surgery, tight glycaemic control by
intensive insulin therapy can halve mortality rates.
22nd International Symposium on Intensive Care and Emergency Medicine
Brussels, March 2002
- Levosimendan, a drug with a novel calcium sensitising action, is
shown to effectively enhance cardiac output for patients with severe,
acutely decompensated heart failure.
Eighth World Congress of Intensive and Critical
Care Medicine
Sydney, October 2001
- B-type natriuretic peptide (BNP) is recognised as a sensitive new
marker for heart failure and its response to therapy.
Fifth Annual Meeting of the Heart Failure Society of America (HFSA)
Washington, DC, September 2001
- Results of the Euro Heart Survey Programme on Heart Failure reveal
gaps between evidence-based and actual practices.
European Society of Cardiology Congress XXIII
Stockholm, September 2001
- New 2001 European Society of Cardiology guidelines for treatment of
patients with heart failure are introduced.
Heart Failure 2001
Barcelona, June 2001
|
|
